Chemical Compound
Platinum, [(1S,2S)-1,2-cyclohexanediamine-kappaN1,kappaN2][ethanedioato(2-)-kappaO1,kappaO2]-, (SP-4-2)-; Platinum, (1,2-cyclohexanediamine-kappaN,kappaN')[ethanedioato(2-)-kappaO1,kappaO2]-, [SP-4-2-[1S-(trans)]]-; Platinum, [(1S,2S)-1,2-cyclohexanediamine-kappaN,kappaN'][ethanedioato(2-)-kappaO1,kappaO2]- (9CI); 1,2-Cyclohexanediamine, platinum complex, (1S-trans)-; [(1S,2S)-1,2-Cyclohexanediamine-kappaN1,kappaN2][ethanedioato(2-)-kappaO1,kappaO2]platinum; NSC 266042; Platinum, (1,2-cyclohexanediamine-N,N')[ethanedioato(2-)-O,O']-, [SP-4-2-(1S-trans)]-; (SP-4-2)-[(1S,2S)-Cyclohexane-1,2-diamine-kappaN,kappaN'][ethanedioato(2-)-kappaO1,kappaO2]platinum; Oxaliplatin Imp. D (EP); (S,S)-Oxaliplatin; Oxaliplatin Related Compound D (USP)
CAS Registry Number
61758-77-8
Primary record
Platinum, [(1S,2S)-1,2-cyclohexanediamine-kappaN1,kappaN2][ethanedioato(2-)-kappaO1,kappaO2]-, (SP-4-2)-; Platinum, (1,2-cyclohexanediamine-kappaN,kappaN')[ethanedioato(2-)-kappaO1,kappaO2]-, [SP-4-2-[1S-(trans)]]-; Platinum, [(1S,2S)-1,2-cyclohexanediamine-kappaN,kappaN'][ethanedioato(2-)-kappaO1,kappaO2]- (9CI); 1,2-Cyclohexanediamine, platinum complex, (1S-trans)-; [(1S,2S)-1,2-Cyclohexanediamine-kappaN1,kappaN2][ethanedioato(2-)-kappaO1,kappaO2]platinum; NSC 266042; Platinum, (1,2-cyclohexanediamine-N,N')[ethanedioato(2-)-O,O']-, [SP-4-2-(1S-trans)]-; (SP-4-2)-[(1S,2S)-Cyclohexane-1,2-diamine-kappaN,kappaN'][ethanedioato(2-)-kappaO1,kappaO2]platinum; Oxaliplatin Imp. D (EP); (S,S)-Oxaliplatin; Oxaliplatin Related Compound D (USP)
- 库存
- 2,951 克
- 纯度
- 98.8 %
- CAS
- 61758-77-8
化合物标识与属性
- CAS
- 61758-77-8
- PubChem CID
- 129011604
- SMILES
- C1CC[C@@H]([C@H](C1)N)N.C(=O)(C(=O)[O-])[O-].[Pt+4]
- Canonical SMILES
- N[C@H]1CCCC[C@@H]1N.O=C([O-])C(=O)[O-].[Pt+4]
名称与同义词
- (S,S)-Oxaliplatin
- Oxaliplatin EP Impurity D
- Oxaliplatin impurity D CRS
- CS-T-59979
- 61758-77-8
- Platinum, [(1S,2S)-1,2-cyclohexanediamine-kappaN1,kappaN2][ethanedioato(2-)-kappaO1,kappaO2]-, (SP-4-2)-; Platinum, (1,2-cyclohexanediamine-kappaN,kappaN')[ethanedioato(2-)-kappaO1,kappaO2]-, [SP-4-2-[1S-(trans)]]-; Platinum, [(1S,2S)-1,2-cyclohexanediamine-kappaN,kappaN'][ethanedioato(2-)-kappaO1,kappaO2]- (9CI); 1,2-Cyclohexanediamine, platinum complex, (1S-trans)-; [(1S,2S)-1,2-Cyclohexanediamine-kappaN1,kappaN2][ethanedioato(2-)-kappaO1,kappaO2]platinum; NSC 266042; Platinum, (1,2-cyclohexanediamine-N,N')[ethanedioato(2-)-O,O']-, [SP-4-2-(1S-trans)]-; (SP-4-2)-[(1S,2S)-Cyclohexane-1,2-diamine-kappaN,kappaN'][ethanedioato(2-)-kappaO1,kappaO2]platinum; Oxaliplatin Imp. D (EP); (S,S)-Oxaliplatin; Oxaliplatin Related Compound D (USP)